Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Days Payable is 76.89 as of Feb. 2026, which is 5% below its 10-year median of 81.03. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 607 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks better than 61.12% on this metric.
The historical rank and industry rank for COSMOS Pharmaceutical's Days Payable or its related term are showing as below:
CSMYF'
s Days Payable Range Over the Past 10 Years
Min: 75.74 Med: 81.03 Max: 84.63
Current: 75.74
During the past 13 years, COSMOS Pharmaceutical's highest Days Payable was 84.63. The lowest was 75.74. And the median was 81.03.
CSMYF's Days Payable is ranked better than 61.12% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs CSMYF: 75.74
COSMOS Pharmaceutical Days Payable Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Days Payable distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
COSMOS Pharmaceutical's Days Payable for the fiscal year that ended in May. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (CSMYF) has a Days Payable of 76.89 as of Feb. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on COSMOS Pharmaceutical and its competitors. This is near median its historical median of 81.03. Over the past decade, COSMOS Pharmaceutical's Days Payable has ranged from 75.74 to 84.63. According to the industry distribution chart, COSMOS Pharmaceutical ranks #236 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 38.9%.
Is COSMOS Pharmaceutical's Days Payable too high?
COSMOS Pharmaceutical's current Days Payable of 76.89 is near median its 10-year median of 81.03. Over the past 10 years, this metric has ranged from a low of 75.74 to a high of 84.63. The Healthcare Providers & Services industry median Days Payable is 57.13. COSMOS Pharmaceutical's value of 76.89 is 34.6% above this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #236 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #236 out of 607 companies for Days Payable. This puts COSMOS Pharmaceutical in the upper half of its industry. The industry median Days Payable is 57.13. COSMOS Pharmaceutical's value of 76.89 is 34.6% above this benchmark. Historically, COSMOS Pharmaceutical's own Days Payable has ranged from 75.74 to 84.63 over the past decade. While the company's 10-year median is 81.03 vs. the industry median of 57.13, COSMOS Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Days Payable of 76.89 is 34.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Days Payable is 76.89, which is near median its own 10-year median of 81.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Days Payable is 76.89, which is near median its 10-year median of 81.03 and 34.6% above the Healthcare Providers & Services industry median of 57.13. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Days Payable is 76.89 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Days Payable: 76.89 (near median its 10-year median of 81.03)
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 34.6% above the Healthcare Providers & Services median (#236 of 607)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
